Somatic <i>MED12</i> mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms

Abstract

Specific somatic MED12 mutations in prostate cancer and uterine leiomyomas accumulate in two separate regions of the gene and promote tumorigenesis through clearly distinct mechanisms.